Title: Antibiotics Market Analysis, Size, Growth rate and Forecasts to 2026
1Antibiotics Market To Reach USD 63.34 Billion By
2026
www.reportsanddata.com
sales_at_reportsanddata.com
2 Market Summary
Increase in number of chronic diseases coupled
with technological advancements globally, are the
major factors influencing market
growth. Antibiotics Market Size USD 46.23
billion in 2018, Market Growth - CAGR of 3.9,
Market Trends Technological advancement along
with increasing chronic diseases
3 Our Approach
Market Summary
- The Antibiotics Market is estimated to reach USD
63.34 Billion by 2026, according to a new report
by Reports and Data. This can be mainly
associated with the growing incidences of
infectious diseases such as pneumonia, HIV/AIDS,
malaria, and tuberculosis along with
technological advancements that are expected to
become the most common growth factors globally in
the coming years. - Expanding efforts initiated by the key companies
for the development of advanced products will
boost market growth. A report by the Pew
Charitable Trust states, about 37 promising
molecules were investigated within the U.S.
market in March 2016. Majority of which are in
clinical trials phase II and are expected to hit
the market in the coming years. Moreover,
supportive government enactments, such as the
GAIN (Generating Antibiotics Incentives Now) Act,
is anticipated to facilitate the approval
process. GAIN Act has plans, which promote the
advancement of therapies against
antibiotic-resistant pathogens. Diarrhea is one
of the leading causes of death among children
across the globe, and it requires antibiotic
mediation to reduce the death rate. Other
infectious diseases that may boost the growth of
the market are pneumonia, HIV/AIDS, malaria, and
tuberculosis. Moreover, the development of new
infections, such as the Ebola virus and Zika, are
also promoting the development and growth of the
antibiotics market. - Key participants include Bristol-Myers Squibb
Co., AstraZeneca plc, The Menarini Group,
GlaxoSmithKline plc, Bayer HealthCare AG, Eli
Lilly and Company, Merck Co., Inc., Johnson
Johnson, Novartis AG, Teva Pharmaceutical
Industries Ltd., Sanofi - To Get Sample Copy of Report visit _at_
https//www.reportsanddata.com/sample-enquiry-form
/1377
4 Our Approach
Market Summary
- For the purpose of this study, Reports and Data
have segmented the global Antibiotics Market on
the basis of Type, End user, Product,
Administration mode and region - By Type Outlook (Revenue, USD Million 2016-2026)
- RNA Synthesis Inhibitors
- DNA Synthesis Inhibitors
- Cell Wall Synthesis Inhibitors
- Protein Synthesis Inhibitors
- Mycolic Acid Inhibitors
- By End-User Outlook (Revenue, USD Million
2016-2026) - Retail pharmacies
- Online pharmacies
- Hospital pharmacies
- Click here to avail the report at an unbelievable
discount rate _at_ https//www.reportsanddata.com/dis
count-enquiry-form/1377
5 Our Approach
Market Summary
- Product Outlook (Revenue, USD Million 2016-2026)
- Carbapenems
- Penicillin
- Fluoroquinolones
- Macrolides
- Others
- Administration mode Outlook (Revenue, USD
Million 2016-2026) - Oral
- Topical
- Sublingual
- Inhalation
- Others
6 Our Approach
Market Summary
- Further key findings from the report suggest
- Antibiotics are a combination of medicines used
in the treatment of infections or diseases caused
by bacteria, germs, and some parasites-by
restraining the growth of microorganisms or
destroying them. - Antibiotics are also named as antimicrobials or
antibacterial. - Increase in the prevalence of persistent and
infectious diseases across the globe and the
ability of antibiotics to treat a broad spectrum
of bacterial infections have led to the
accelerated growth of the global market. - Since the development of the antibiotic
penicillin in 1920, several antibiotic compounds
have been used to treat various bacterial
infections. - Growing population, increasing rates of chronic
diseases, and rising healthcare expenditures are
the fundamental factors which are boosting the
growth of the market across the globe. - Development of various antiviral drugs, which
hinder transcription and reverse transcription
methods, are expected to boost the growth. - DNA synthesis inhibitors of the type segment are
anticipated to grow at the highest rate of 4.1
during the forecast period. - Read More _at_ https//www.reportsanddata.com/report-
detail/antibiotics-market
7 Our Approach
About Us
- Reports and Data is a market research and
consulting company that provides syndicated
research reports, customized research reports,
and consulting services. Our solutions purely
focus on your purpose to locate, target and
analyze consumer behavior shifts across
demographics, across industries and help clients
make a smarter business decision. We offer market
intelligence studies ensuring relevant and
fact-based research across a multiple industries
including Healthcare, Technology, Chemicals,
Power, and Energy. We consistently update our
research offerings to ensure our clients are
aware about the latest trends existent in the
market. Reports and Data has a strong base of
experienced analysts from varied areas of
expertise. - Contact Us
- John Watson
- Head of Business Development
- Reports And Data Web www.reportsanddata.com
- Direct Line 1-212-710-1370
- E-mail sales_at_reportsanddata.com